Background There is lack of information on the magnitude of depression among elderly
population in India. This systematic review and meta-analysis aimed to estimate the prevalence …

Background Ivermectin is one among several potential drugs explored for its therapeutic and
preventive role in SARS-CoV-2 infection. The study was aimed to explore the association …

Globally, more than 350 million people of all ages suffer from depression. In spite of the high
burden, depression is often unrecognized and undertreated. Inaccurate assessment is one …

While there is evidence of morbidity compression in many countries, temporal patterns of
non-communicable diseases (NCDs) in developing countries, such as India, are less clear. …

Cancer is one of the important causes of morbidity and mortality in India. Globally, out of 14
million diagnosed new cancer cases slightly more than 1 million were from India. Population …

Background. Globally, more than 350 million people of all ages suffer from depression.
Elderly persons are more vulnerable to depression. We conducted this study to estimate the …

India imposed one of the world’s strictest population-wide lockdowns on March 25, 2020 for
COVID-19. We estimated epidemiological parameters, evaluated the effect of control …

India approved COVID-19 vaccine called Covaxin, developed by the Indian Council of Medical
Research and Bharat Biotech Ltd. The primary objective of the study was to estimate the …

Objectives India introduced BBV152/Covaxin and AZD1222/Covishield vaccines in January
2021. We estimated the effectiveness of these vaccines against severe COVID-19 among …

Background: After SARS-CoV-2 set foot in India, the Government took a number of steps to
limit the spread of the virus in the country. This included restricted testing, isolation, contact …